[Effect of EM201, an in vivo metabolite of erythromycin (EM), on signal transduction of IL-2 receptor].
Osawa
Mizuho
M
Sunazuka
Toshiaki
T
Sawai
Tetsuo
T
Omura
Tomo
T
Akagawa
Kiyoko
K
D002478:Cells, Cultured; D002867:Chromones / Q000494:pharmacology; D004917:Erythromycin / Q000031:analogs & derivatives* / Q000494:pharmacology; D005419:Flavonoids / Q000494:pharmacology; D006801:Humans; D009000:Monocytes / Q000502:physiology; D009025:Morpholines / Q000494:pharmacology; D015375:Receptors, Interleukin-2 / Q000502:physiology*; D015398:Signal Transduction / Q000187:drug effects*; D020123:Sirolimus / Q000494:pharmacology
D002867:Chromones; D005419:Flavonoids; D009025:Morpholines; D015375:Receptors, Interleukin-2; C085911:2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one; C093673:8,9-anhydroerythromycin A 6,9-hemiketal; D004917:Erythromycin; C093973:2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one; D020123:Sirolimus